ConverGen AI is a research and advisory firm that enables the responsible development and deployment of clinical GenAI solutions by healthcare organizations. Our research is focused on combining technical, regulatory, commercial, and clinical insights to develop streamlined GenAI governance solutions for healthcare organizations. We apply this interdisciplinary approach to implement an auditable ISO 42001-compliant AI Management System (AIMS) that ensures GenAI solutions can be relied upon to improve healthcare outcomes and experiences.
Company Details
- Founded
- -
- Address
- Brooklyn, Ny 11215, Us
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- converge-res.com
- Keywords
- ISO 42001 Certification for AI Management Systems (AIMS), GenAI Governance, Regulatory Compliance with AI Regulations, Design & Implementation of AI Management Systems (AIMS), Clinical Evaluation Process Innovation, FDA’s Medical Product Review Process, Software-as-a-Medical Device (SaMD) Clinical Evaluation, Scientific Analysis.
- HQ
- Brooklyn, NY
Convergen Ai Questions
Convergen Ai's website is converge-res.com
Convergen Ai's LinkedIn profile is https://www.linkedin.com/company/convergenai
Convergen Ai's industry is
Research Services
Convergen Ai's top competitors are
Fuzy.ai | Product Science As A Service,
Project Olympus Cmu,
Mindmint Solutions,
R3i Foundation (Residual Risk Reduction),
Orion,
Ponto Care,
The Ivy Tutors.com,
Novastro Chain,
Pantheonai,
Ai Mindsystems Foundation.
Convergen Ai's categories are Research Services
Convergen Ai's founding year is 2017
